The U.S. FDA approved Merck & Co. Inc.’s Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection on Sept. 19, making it the first and only subcutaneously (SC)-administered immune ...
The Chosun Ilbo on MSN
In vivo CAR-T therapy promises single injection cancer treatment
Will a world where cancer is treated with a single injection arrive? The so-called “in vivo CAR-T” method, which directly alters immune cells within the body through injections, is recently changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results